Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients New to Insulin Therapy Who Were Inadequately Controlled on Oral Agents

NCT00036504 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00036504
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00036504 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients New to Insulin Therapy Who Were Inadequately Controlled on Oral Agents
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2001
Completion date
August 31, 2002
Enrollment
100
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus